Professor Bowtell holds joint appointments at the Peter MacCallum Cancer Centre and the Garvan Institute. He was Director of Research at Peter Mac from 2000-2009. Professor Bowtell has an extensive background human cancer genomics, particularly ovarian cancer. He is PI for the Australian Ovarian Cancer Study, one of the largest population-based cohort studies of ovarian cancer in the world, and is CIA for a newly initiated NHMRC Program grant. His lab has made practice-changing contributions to the molecular classification of ovarian cancer, the impact of BRCA mutations on treatment response, and mechanisms of primary and acquired chemotherapy resistance.